Boston, MA
Company Info
| Phone: | (732) 590-2900 |
| Year Established: | 1991 |
| Ticker: | OXUR |
| Exchange: | Euronext Brussels |
Contacts
| Primary: | Tom Graney, CFA CEO |
| Other: | Micha�l Dillen CBO Kathleen Paisley CLO & General Counsel Andy De Deene, MD, MBA CDO |
Company Description
Oxurion, formerly ThromboGenics, is a biopharmaceutical company focused on developing novel treatments for back of the eye diseases with an innovative pipeline in diabetic eye disease.
